MergerJun 26, 2026, 05:26 PM

Select Medical Stockholders Approve Merger with Consortium

AI Summary

Select Medical Holdings Corporation announced that its stockholders approved the previously announced merger agreement with a consortium led by Robert A. Ortenzio, Martin F. Jackson, and Welsh, Carson, Anderson & Stowe (WCAS). The merger proposal received approval from over 79.88% of outstanding shares and over 76.64% of unaffiliated shares. The company anticipates the merger will close on or about June 30, 2026, subject to the terms and conditions of the merger agreement. Stockholders also approved, on a non-binding advisory basis, certain executive compensation related to the merger.

Key Highlights

Select Medical stockholders approved the merger proposal at a special meeting on June 26, 2026.
The merger was approved by over 79.88% of outstanding shares and over 76.64% of unaffiliated shares.
The merger is with a consortium led by Robert A. Ortenzio, Martin F. Jackson, and Welsh, Carson, Anderson & Stowe (WCAS).
The company anticipates the merger will close on or about June 30, 2026.
A non-binding, advisory proposal for executive compensation related to the merger was also approved with 52,322,733 votes For.
82.54% of the company's common stock was present or represented by proxy at the meeting, constituting a quorum.

View SEC Filing

SEM

Hospital/Nursing Management

SELECT MEDICAL HOLDINGS CORP

Price Impact